InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
InnovAge Holding Corp.NASDAQ: INNV
Capital Expenditures · Q3 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $3.6M (cash outflow) rose 24.3% year over year, ahead of the +16.8% change in trailing-twelve-month capital expenditures. Sequentially, it rose 52.5% from the prior quarter. Over 3 fiscal years it compounded at -45.3% a year.
Context
- Capital expenditures amounted to 0.7% of revenue in FY2025, down 0.3 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +24.3% holds above the trailing-twelve-month pace of +16.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (6.26M) USD
- Year-over-year change
- +20.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (6.26M) | +20.9% |
| FY2024 | 2024-06-30 | (7.91M) | +0.0% |
| FY2023 | 2023-06-30 | (7.91M) | +79.3% |
| FY2022 | 2022-06-30 | (38.24M) | -118.0% |
| FY2021 | 2021-06-30 | (17.54M) | — |
Capital Expenditures vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 capital expenditures of $11.39M is the 6th largest of the 8 companies compared; the peer median is $31.7M.
- Its year-over-year change of +16.8% is the 5th highest of 8, against a peer median of +34.6%.
- Capital expenditures amounts to 1.2% of revenue for INNV, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $217.71M | +15.7% | +0.8% | 7.4% | |
| LTM Jun 2026 | $189.34M | +1.7% | +30.3% | 3.5% | |
| LTM Sep 2026 | $46.05M | +34.6% | +6.5% | 2.9% | |
| LTM Mar 2026 | $31.7M | +14.3% | +10.7% | 7.7% | |
| LTM Mar 2026 | $18.77M | +113.1% | +15.8% | 1.8% | |
| LTM Mar 2026 | $11.39M | +16.8% | -45.3% | 1.2% | |
| LTM Oct 2026 | $9.7M | +38.1% | -14.7% | 0.4% | |
| LTM Jun 2026 | $9.34M | +38.1% | -2.4% | 0.6% | |
| Peer median (excluding INNV) | $31.7M | +34.6% | +6.5% | 2.9% | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (43.99M) | (6.52M) | (23.22M) | (23.22M) | (35.34M) |
| Depreciation & Amortization | 13.35M | 14.35M | 18.95M | 18.95M | 19.51M |
| Deferred Income Tax | 0 | 0 | 1.22M | 1.22M | 1.3M |
| Stock-Based Compensation | 47.05M | 3.74M | 6.83M | 6.83M | 7.62M |
| Change in Working Capital | (2.59M) | (7.4M) | (52.15M) | (52.15M) | 15.24M |
| Accounts Receivables | 5.88M | (9.51M) | (33.4M) | (30.33M) | 11.22M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 1.37M | 1.37M | 20.43M |
| Other Working Capital | (8.47M) | 2.11M | (20.12M) | (23.18M) | (16.42M) |
| Other Non-Cash Items | (21.37M) | 23.13M | 11.46M | 11.46M | 24.54M |
| Operating Cash Flow | (7.55M) | 27.3M | (36.9M) | (36.9M) | 32.87M |
| Capital Expenditures | (17.54M) | (38.24M) | (7.91M) | (7.91M) | (6.26M) |
| Acquisitions (Net) | 0 | 0 | (19.07M) | (19.07M) | (3.52M) |
| Purchases of Investments | 0 | 0 | (2.39M) | (2.39M) | (2.07M) |
| Sales of Investments | 0 | 0 | 3M | 3M | 6.3M |
| Other Investing Activities | (2M) | (2M) | 0 | 0 | 0 |
| Investing Cash Flow | (19.54M) | (40.24M) | (26.37M) | (26.37M) | (5.55M) |
| Debt Repayment | (139.45M) | (6.32M) | (8.43M) | (8.43M) | (9.91M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (77.6M) | 0 | (179K) | (179K) | (7.32M) |
| Dividends Paid | (9.5M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 342.78M | 0 | 1.58M | 1.58M | (1.86M) |
| Financing Cash Flow | 116.22M | (6.32M) | (7.03M) | (7.03M) | (19.08M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 89.14M | (19.25M) | (70.31M) | (70.31M) | 8.23M |
| Free Cash Flow | (25.09M) | (10.94M) | (44.81M) | (44.81M) | 26.6M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.